Elevated soluble adhesion molecules in women with pre-eclampsiaDo cytokines like tumour necrosis factor-α and interleukin-1β cause endothelial activation?

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 86, Issue 1, 1999, Pages 35-41

  Heyl, Wolfgang ^a   Handt, Stefan ^a   Reister, Frank ^a   Gehlen, Johanna ^a   Schröder, Willibald ^a   Mittermayer, Christian ^a   Rath, Werner ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HELLP SYNDROME; HUMAN; PREECLAMPSIA; PRIORITY JOURNAL;

EID: 0032807677     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(99)00042-1     Document Type: Article

References (26)

1. Roberts J.M., Taylor R.N., usci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Pre-eclampsia: An endothelial disorder. Am J Obstet Gynecol. 161:1989;1200-1204.
2. Gordon J.L., Edwards R.M., Cashman S.J., Rees A.J., Gearing A.J.H. Circulating endothelial adhesion molecules. Catravas J.D., Callow A.D., Ryan U.S. Vascular Endothelium - Physiological Basis of Clinical Problems. 1993;115-122 Plenum Press, New York.
3. Harlan J.M., Winn R.K., Vedder N.B. Proinflammatory role of leukocyte adhesion molecules. Catravas J.D., Callow A.D., Ryan U.S. Vascular Endothelium - Physiological Basis of Clinical Problems. 1993;99-105 Plenum Press, New York.
4. Lyall F., Greer I.A., Boswell F., Macara L.M., Walker J.J., Kingdom J.C.P. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leukocyte activation? Br J Obstet Gynecol. 101:1994;485-487.
5. Austgulen R., Lien E., Vince G., Redman C.W.G. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 71:1997;53-58.
6. Fickling S.A., Whitley G.S., Nussey S.S. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leukocyte activation? [letter; comment]. Br J Obstet Gynaecol. 102:1995;173-174.
7. Krauss T., Kuhn W., Lakoma C., Augustin H.G. Circulating endothelial cell adhesion molecules as diagnostic markers for early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol. 177:1997;443-449.
8. Haller H., Ziegler E.M., Homuth V., Drab M., Eichhorn J., Nagy Z., Busjahn A., Vetter K., Luft F.C. Endothelial Adhesion molecules and leukocyte integrins in preeclamptic patients. Hypertension. 29[part 2]:1997;291-296.
9. Halim A., Kanayama N., el-Maradny E., Nakashima A., Bhuiyan A.B., Khatun S., Terao T. Plasma P selectin (GMP-140) and glycocalicin are elevated in pre-eclampsia and eclampsia: their significances. Am J Obstet Gynecol. 174:1996;272-277.
10. Mantovani A., Bussolino F., Dejana E. Cytokine regulation of endothelial cell function. FASEB J. 6:1992;2591-2599.
11. Introna M., Brevario F., d'Aniello E., Dejana E., Mantovani A. Modulation of endothelial cell function by cytokines. Catravas J.D., Callow A.D., Ryan U.S. Vascular Endothelium - Physiological Basis of Clinical Problems II. 1993;107-113 Plenum Press, New York.
12. Nesselhut T., Rath W., Balwanz A., Kuhn W. Study of the changes of the immune status in patients suffering from PIH. Cosmi E.V., Di Renzo G.C. Hypertension in Pregnancy. 1991;343-346 Mundozzi Editore, Bologna.
13. Kupferminc M.J., Peaceman A.M., Wigton T.R., Rehnberg K., Socol M.L. Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe pre-eclampsia. Am J Obstet Gynecol. 170:1994;1752-1759.
14. Greer I.A., Lyall F., Perera T., Boswell F., Macara L.M. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with pre-eclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 84:1994;937-940.
15. Visser W., Beckmann I., Bremer H.A., Lim H.L., Wallenburg H.C.S. Bioactive tumour necrosis factor α in pre-eclamptic patients with and without HELLP syndrome. Br J Obstet Gynecol. 101:1994;1081-1082.
16. Schröcksnadel H., Herold M., Steckel-Berger G., Fuchs D., Wachter H., Dapunt O. Cell-mediated immunity in hypertensive disorders of pregnancy. Geburtsh u Frauenheilk. 52:1992;592-595.
17. Vince G.S., Starkey P.M., Austgulen R., Kwiatkowski D., Redman C. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynecol. 102:1995;20-25.
18. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 142:1982;159-167.
19. Weinstein L. Pre-eclampsia/Eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia. Obstet Gynecol. 66:1985;657-660.
20. Davey D.A., MavGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 158:1988;892-898.
21. Knorr R., Dustin M.L. The lymphocyte function-associated antigen (LFA)-1 I domain is a transient binding molecule for intercellular adhesion molecule (ICAM)-1 and ICAM-3 in hydrodynamic flow. J Exp Med. 186:1997;719-730.
22. Heyl W., Handt S., Reister F., Gehlen J., Mittermayer C., Rath W. The role of soluble adhesion molecules for evaluating endothelial cell activation in preeclampsia. Am J Obstet Gynecol. 180:1999;68-72.
23. Schiff E., Friedman S.A., Baumann P., Sibai B.M., Romero R. Tumor necrosis factor-α in pregnancies associated with pre-eclampsia or small-for-gestational-age newborns. Am J Obstet Gynecol. 170:1994;1224-1229.
24. Meekins J.W., McLaughkin P.J., West D.C., McFadyen I.R., Johnson P.M. Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha) and the development of pre-eclampsia. Clin Exp Immunol. 98:1994;110-114.
25. Opsjon S.L., Austgulen R., Waage A. Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders. Acta Obstet Gynecol Scand. 74:1995;19-26.
26. Kupferminc M.J., Peaceman A.M., Aderka D., Wallach D., Socol M.L. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol. 88:1996;420-427.